EMA — authorised 28 January 2022
- Marketing authorisation holder: Pfizer Europe MA EEIG
- Local brand name: Paxlovid (Copackaged)
- Status: approved
🇪🇺 Paxlovid (Copackaged) in European Union
EMA authorised Paxlovid (Copackaged) on 28 January 2022
Marketing authorisation
Paxlovid (Copackaged) in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in European Union
Frequently asked questions
Is Paxlovid (Copackaged) approved in European Union?
Yes. EMA authorised it on 28 January 2022.
Who is the marketing authorisation holder for Paxlovid (Copackaged) in European Union?
Pfizer Europe MA EEIG holds the EU marketing authorisation.